Nayak Asha 4
4 · Sage Therapeutics, Inc. · Filed Jun 8, 2018
Insider Transaction Report
Form 4
Nayak Asha
Director
Transactions
- Award
Stock Option (Right to Buy)
2018-06-06+10,000→ 10,000 totalExercise: $154.06Exp: 2028-06-06→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The stock option award was issued pursuant to the Sage Therapeutics, Inc., 2014 Stock Option and Incentive Plan. The option will vest in full upon the earlier to occur of June 6, 2019 or the day immediately prior to the 2019 Annual Meeting of Sage's stockholders, subject to continued service as a director on such date.